心脏治疗中的药物基因组学:为心脏健康提供个性化治疗
Niloofar Naderi1, Amir Ghaffari Jolfayi2, Amir Azimi2
1Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
概括
遗传学显著影响心血管疾病 (CVD),影响诸如心肌病和心律失常等疾病. 了解遗传因素可以实现个性化医疗和量身定制的治疗,以获得更好的患者结果.
科学领域:
- 心血管医学 心血管医学
- 人类遗传学 人类遗传学
- 药物基因组学 药物基因组学
背景情况:
- 心血管疾病 (CVD) 是全球主要的健康负担,对发病率和死亡率作出重大贡献.
- 遗传因素,包括单基因和多基因影响,是各种心血管疾病的发展不可或缺的组成部分,包括心肌病,动脉病,脂质不良和心律失常.
- 这些遗传倾向往往与危及生命的事件有关,例如成人突然心脏病死亡 (SCD),这凸显了早期检测和干预的必要性.
研究的目的:
- 探索遗传学和药物遗传学在心血管医学中的关键作用.
- 阐明遗传洞察如何提高心血管疾病风险分层.
- 检查遗传信息在指导心血管疾病治疗策略中的应用.
主要方法:
- 对心血管医学中遗传和药物遗传影响的当前文献的综述.
- 分析遗传查和诊断如何为个人和家庭提供及时干预.
- 检查分子遗传学和药物基因组学对个性化心血管治疗的进展.
主要成果:
- 遗传因素是各种心血管疾病发展的关键决定因素,包括心肌病,心律失常和脂质不良.
- 早期遗传查和诊断对于及时干预至关重要,有利于受影响的个人和处于危险的家庭成员.
- 药物基因组学的进步允许根据个体遗传特征进行量身定制的药物选择和剂量,从而实现个性化的心血管治疗.
结论:
- 基因洞察力正在改变心血管医学,改善风险分层并指导个性化的治疗干预措施.
- 药物遗传学的考虑对于优化各种心血管药物的使用至关重要,包括抗凝血剂,抗血小板剂和降脂疗法.
- 基于遗传信息的个性化临床干预措施的实施对于实现心血管医学中最佳的患者护理和结果至关重要.
更多相关视频
08:29A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation
Published on: March 21, 2025
883
10:30Technical Applications of Microelectrode Array and Patch Clamp Recordings on Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: August 4, 2022
3.0K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
01:26Heart Failure Drugs: Inotropic Agents
724
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
724
01:29Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
01:29Pathophysiology of Cardiac Performance
805
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
805
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
509
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
509
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
129
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
129